Abstract
Background
Suspicion of cancer in the Emergency Department (ED) may lead to potentially avoidable and prolonged admissions. We aimed to examine the reasons for potentially avoidable and prolonged hospitalizations after admissions from the ED for new colon cancer diagnoses (ED-dx).
Methods
A retrospective, single-institution analysis was conducted of patients with ED-dx between 2017 and 2018. Defined criteria were used to identify potentially avoidable admissions. Patients without avoidable admissions were examined for ideal length of stay (iLOS), using separate defined criteria. Prolonged length of stay (pLOS) was defined as actual length of stay (aLOS) being greater than 1 day longer than iLOS.
Results
Of 97 patients with ED-dx, 12% had potentially avoidable admissions, most often (58%) for cancer workup. Very little difference in demographic, tumor characteristics, or symptoms were found, except patients with potentially avoidable admissions were more functional (Eastern Cooperative Oncology Group [ECOG] score 0–1: 83% vs. 46%; p = 0.049) and had longer symptom duration prior to ED presentation {24 days (interquartile range [IQR] 7–75) vs. 7 days (IQR 2–21)}. Among the 60 patients who had necessary admissions but did not require urgent intervention, 78% had pLOS, most often for non-urgent surgery (60%) and further oncologic workup. The median difference between iLOS and aLOS was 12 days (IQR 8–16) for pLOS.
Conclusions
Potentially avoidable admissions following Ed-dx were uncommon but were mostly for oncologic workup. Once admitted, the majority of patients had pLOS, most often for definitive surgery and further oncologic workup. This suggests a lack of systems to safely transition to outpatient cancer management.
Similar content being viewed by others
References
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. https://doi.org/10.3322/caac.21708.
Issa IA, Noureddine M. Colorectal cancer screening: an updated review of the available options. World J Gastroenterol. 2017;23(28):5086–96. https://doi.org/10.3748/wjg.v23.i28.5086.
Balchen V, Simon K. Colorectal cancer development and advances in screening. Clin Interv Aging. 2016;11:967–76. https://doi.org/10.2147/CIA.S109285.
Ladabaum U, Mannalithara A, Meester RGS, Gupta S, Schoen RE. Cost-effectiveness and national effects of initiating colorectal cancer screening for average-risk persons at age 45 years instead of 50 years. Gastroenterology. 2019;157(1):137–48. https://doi.org/10.1053/j.gastro.2019.03.023.
Nawaz H, Via C, Shahrokni A, et al. Can the inpatient hospital setting be a golden opportunity to improve colon cancer screening rates in the united states? Health Promot Pract. 2014;15(4):506–11. https://doi.org/10.1177/1524839913518559.
Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American cancer society. CA Cancer J Clin. 2018;68(4):250–81. https://doi.org/10.3322/caac.21457.
Joseph DA. Use of colorectal cancer screening tests by state. Prev Chronic Dis. 2018. https://doi.org/10.5888/pcd15.170535.
Colorectal Cancer Screening | Cancer Trends Progress Report. Available at: https://progressreport.cancer.gov/detection/colorectal_cancer. Accessed 23 Aug 2022.
Weithorn D, Arientyl V, Solsky I, et al. Diagnosis setting and colorectal cancer outcomes: the impact of cancer diagnosis in the emergency department. J Surg Res. 2020;255:164–71. https://doi.org/10.1016/j.jss.2020.05.005.
Amri R, Bordeianou LG, Sylla P, Berger DL. Colon cancer surgery following emergency presentation: effects on admission and stage-adjusted outcomes. Am J Surg. 2015;209(2):246–53. https://doi.org/10.1016/j.amjsurg.2014.07.014.
Brooks GA, Abrams TA, Meyerhardt JA, et al. Identification of potentially avoidable hospitalizations in patients with GI cancer. J Clin Oncol. 2014;32(6):496–503. https://doi.org/10.1200/JCO.2013.52.4330.
Johnson PC, Xiao Y, Wong RL, et al. Potentially avoidable hospital readmissions in patients with advanced cancer. J Oncol Pract. 2019;15(5):e420–7. https://doi.org/10.1200/JOP.18.00595.
El-Jawahri A, Keenan T, Abel GA, et al. Potentially avoidable hospital admissions in older patients with acute myeloid leukaemia in the USA: a retrospective analysis. Lancet Haematol. 2016;3(6):e276-283. https://doi.org/10.1016/S2352-3026(16)30024-2.
Caterino JM, Adler D, Durham DD, et al. Analysis of Diagnoses, Symptoms, Medications, and Admissions Among Patients With Cancer Presenting to Emergency Departments. JAMA Netw Open. 2019;2(3):e190979. https://doi.org/10.1001/jamanetworkopen.2019.0979.
Yabroff KR, Lamont EB, Mariotto A, et al. Cost of care for elderly cancer patients in the United states. JNCI J Natl Cancer Inst. 2008;100(9):630–41. https://doi.org/10.1093/jnci/djn103.
Bosch X, Sanclemente-Ansó C, Escoda O, et al. Time to diagnosis and associated costs of an outpatient vs inpatient setting in the diagnosis of lymphoma: a retrospective study of a large cohort of major lymphoma subtypes in Spain. BMC Cancer. 2018;18(1):276. https://doi.org/10.1186/s12885-018-4187-y.
Ostby SA, Evans JG, Smith HJ, et al. Reducing emergency department (ED) computed tomography (CT) utilization in women treated for gynecologic cancers. Gynecol Oncol. 2020;156(2):288–92. https://doi.org/10.1016/j.ygyno.2019.11.024.
Jansma B, Vakkalanka P, Talan DA, Negaard B, Faine BA. Guideline adherence for the management of emergency department patients with febrile neutropenia and no infection source: Is there room for improvement? J Oncol Pharm Pract. 2020;26(6):1382–9. https://doi.org/10.1177/1078155219896396.
Chan DKH, Ang JJ. A simple prediction score for prolonged length of stay following elective colorectal cancer surgery. Langenbecks Arch Surg. 2021;406(2):319–27. https://doi.org/10.1007/s00423-020-02030-7.
Bennedsen ALB, Eriksen JR, Gögenur I. Prolonged hospital stay and readmission rate in an enhanced recovery after surgery cohort undergoing colorectal cancer surgery. Colorectal Dis. 2018;20(12):1097–108. https://doi.org/10.1111/codi.14446.
Orive M, Aguirre U, et al. Risk factors affecting hospital stay among patients undergoing colon cancer surgery: a prospective cohort study. Support Care Cancer. 2019;27(11):4133–44. https://doi.org/10.1007/s00520-019-04683-7.
Chiu CC, Hsu WT, Choi JJ, et al. Comparison of outcome and cost between the open, laparoscopic, and robotic surgical treatments for colon cancer: a propensity score-matched analysis using nationwide hospital record database. Surg Endosc. 2019;33(11):3757–65. https://doi.org/10.1007/s00464-019-06672-7.
Kelly M, Sharp L, Dwane F, Kelleher T, Comber H. Factors predicting hospital length-of-stay and readmission after colorectal resection: a population-based study of elective and emergency admissions. BMC Health Serv Res. 2012;12:77. https://doi.org/10.1186/1472-6963-12-77.
Faiz O, Haji A, Burns E, Bottle A, Kennedy R, Aylin P. Hospital stay amongst patients undergoing major elective colorectal surgery: predicting prolonged stay and readmissions in NHS hospitals. Colorectal Dis. 2011;13(7):816–22. https://doi.org/10.1111/j.1463-1318.2010.02277.x.
Rogers MJ, Matheson LM, Garrard B, et al. Cancer diagnosed in the Emergency Department of a Regional Health Service. Aust J Rural Health. 2016;24(6):409–14. https://doi.org/10.1111/ajr.12280.
Pettit N, Sarmiento E, Kline J. Disparities in outcomes among patients diagnosed with cancer in proximity to an emergency department visit. Sci Rep. 2022;12(1):10667. https://doi.org/10.1038/s41598-022-13422-8.
de Santis RB, Wainstein AJA, Machado GCOG, Santos FAV, Melo MRP, Drummond-Lage AP. Cancer patients admitted in the emergency department: A single-centre observational study. Eur J Cancer Care (Engl). 2022;31(6):e13758. https://doi.org/10.1111/ecc.13758.
Foreman S. Montefiore Medical Center in The Bronx, New York: improving health in an urban community. Acad Med J Assoc Am Med Coll. 2004;79(12):1154–61. https://doi.org/10.1097/00001888-200412000-00007.
Mushlin AI, Black ER, Connolly CA, Buonaccorso KM, Eberly SW. The necessary length of hospital stay for chronic pulmonary disease. JAMA. 1991;266(1):80–3.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83. https://doi.org/10.1016/0021-9681(87)90171-8.
Bannay A, Chaignot C, Blotière PO, et al. The best use of the charlson comorbidity index with electronic health care database to predict mortality. Med Care. 2016;54(2):188–94. https://doi.org/10.1097/MLR.0000000000000471.
Azam F, Latif MF, Farooq A, et al. Performance status assessment by using ECOG (Eastern Cooperative Oncology Group) score for cancer patients by oncology healthcare professionals. Case Rep Oncol. 2019;12(3):728–36. https://doi.org/10.1159/000503095.
Parikh AB, Smith W, Sanderson M, et al. Identifying potentially avoidable hospitalizations in medicare patients with prostate cancer: a retrospective analysis. J Oncol Pract. 2019;15(3):e187–94. https://doi.org/10.1200/JOP.18.00560.
Schriner JB, Arientyl V, Kopp A, et al. Understanding factors associated with hospital admission for colon cancer diagnosis and staging work up. J Clin Oncol. 2021;39(3 Suppl):17. https://doi.org/10.1200/JCO.2021.39.3_suppl.17.
Hatam N, Fanusi T, Dehghani M, Vojdani R, Ramzi M, Askarian M. Economic burden of avoidable hospitalizations among patients with Cancer at Namazi Hospital in Shiraz, 2013. Asian Pac J Cancer Prev APJCP. 2017;18(1):177–82. https://doi.org/10.22034/APJCP.2017.18.1.177.
Morden NE, Chang CH, Jacobson JO, et al. End-of-life care for medicare beneficiaries with cancer is highly intensive overall and varies widely. Health Aff (Millwood). 2012;31(4):786–96. https://doi.org/10.1377/hlthaff.2011.0650.
Petrelli F, Tomasello G, Borgonovo K, et al. Prognostic survival associated with left-sided vs right-sided colon cancer: a systematic Review and meta-analysis. JAMA Oncol. 2017;3(2):211–9. https://doi.org/10.1001/jamaoncol.2016.4227.
Helvaci K, Eraslan E, Yildiz F, et al. Comparison of clinicopathological and survival features of right and left colon cancers. J buon. 2019;7:1845.
Shida D, Inoue M, Tanabe T, et al. Prognostic impact of primary tumor location in stage III colorectal cancer-right-sided colon versus left-sided colon versus rectum: a nationwide multicenter retrospective study. J Gastroenterol. 2020;55(10):958–68. https://doi.org/10.1007/s00535-020-01706-7.
Peng J, Li C, Wang F, et al. Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection. Cancer Manag Res. 2018;10:2095–103. https://doi.org/10.2147/CMAR.S163520.
Group the EC. The impact of enhanced recovery protocol compliance on elective colorectal cancer resection: results from an international registry. Ann Surg. 2015;261(6):1153-1159. https://doi.org/10.1097/SLA.0000000000001029
Juo YY, Hyder O, Haider AH, Camp M, Lidor A, Ahuja N. Is minimally invasive colon resection better than traditional approaches?: first comprehensive national examination with propensity score matching. JAMA Surg. 2014;149(2):177–84. https://doi.org/10.1001/jamasurg.2013.3660.
Andriotti T, Goralnick E, Jarman M, et al. The optimal length of stay associated with the lowest readmission risk following surgery. J Surg Res. 2019;239:292–9. https://doi.org/10.1016/j.jss.2019.02.032.
Bilimoria KY, Ko CY, Tomlinson JS, et al. Wait times for cancer Surgery in the United States: trends and predictors of delays. Ann Surg. 2011;253(4):779–85. https://doi.org/10.1097/SLA.0b013e318211cc0f.
Muto T, Bussey HJR, Morson BC. The evolution of cancer of the colon and rectum. Cancer. 1975;36(6):2251–70. https://doi.org/10.1002/cncr.2820360944.
Hamilton SR. The adenoma-adenocarcinoma sequence in the large bowel: Variations on a theme. J Cell Biochem. 1992;50(S16G):41–6. https://doi.org/10.1002/jcb.240501108.
Bagaria SP, Heckman MG, Diehl NN, Parker A, Wasif N. Delay to colectomy and survival for patients diagnosed with colon cancer. J Invest Surg. 2019;32(4):350–7. https://doi.org/10.1080/08941939.2017.1421732.
Simunovic M, Rempel E, Thériault ME, et al. Influence of delays to nonemergent colon cancer surgery on operative mortality, disease-specific survival and overall survival. Can J Surg. 2009;52(4):E79–86.
Hangaard Hansen C, Gögenur M, Tvilling Madsen M, Gögenur I. The effect of time from diagnosis to surgery on oncological outcomes in patients undergoing surgery for colon cancer: A systematic review. Eur J Surg Oncol. 2018;44(10):1479–85. https://doi.org/10.1016/j.ejso.2018.06.015.
Amri R, Bordeianou LG, Sylla P, Berger DL. Treatment delay in surgically-treated colon cancer: does it affect outcomes? Ann Surg Oncol. 2014;21(12):3909–16. https://doi.org/10.1245/s10434-014-3800-9.
Funding
Effort by H. In was supported by NIH-NCI grant 2K12 CA132783-06 (Paul Calabresi Career Development Award). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article was presented at the Academic Surgical Congress Meeting, 2 February 2022, Orlando, FL, USA.
Appendices
Appendix 1
Tool for potentially avoidable admissions for patients with newly diagnosed colon cancer
-
1.
Potentially avoidable admission
-
2.
Insufficient information
-
3.
Unavoidable admission
Use the below criteria to identify patients safe for ED discharge. All criteria must be met to qualify for “potentially avoidable admissions”. If any criteria not met then the patient has “unavoidable admission”. If there is incomplete information to complete the criteria then the patient falls in category 2 “insufficient information”.
Condition | Potentially avoidable admission criteria |
---|---|
General | No persistent hemodynamic instabilitya |
Afebrileb | |
No markers of peritonitis/perforation per laboratory values/physical exam/imaging | |
No urgent need for intervention | |
No concurrent diagnosis requiring admission | |
Tolerating oral diet or implied | |
Pain controlled with oral medications | |
Bleeding/Anemia | No transfusion requirement |
Obstruction | No computed tomography (CT) read of high grade obstructionc |
Evidence of bowel function in ED or immediately prior |
Appendix 2
Resolution criteria for ideal length of stay (iLOS) during colon cancer admissions
Admitting condition | Resolution criteria |
---|---|
Anemia/Bleeding | Per notes, no sign of active bleeding |
No blood transfusions over previous 24 hours | |
Definitive or presumed source of bleeding | |
Three consecutive stable hemoglobin recordings each separated by at least 6 hours OR | |
Two consecutive stable readings separated by at least 20 hours | |
Obstruction | Return of bowel function (flatus, bowel movement, ostomy output, etc.) |
Regular diet is tolerated | |
Sepsis | Source of infection identified |
If indicated, source control is obtained | |
Leukocytosis down trending over 24 hours | |
The patient is on definitive antibiotic therapy or completed antibiotics | |
The patient has either completed antibiotics, is on a oral regimen, or a peripherally inserted central catheter or midline has been placed for outpatient intravenous antibiotic therapy | |
Peritonitis | Operative procedurea |
Improvement in physical exam | |
Pain Control | Pain controlled on oral regimen |
Requiring one or fewer administrations of IV pain medication over proceeding 24 hours | |
Medical Condition Unrelated to Colon Cancer | Required inpatient workup complete |
Inpatient need for treatment resolved |
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tagerman, D.L., Ramos-Santillan, V., Kalam, A. et al. Potentially Avoidable Admissions and Prolonged Hospitalization in Patients with Suspected Colon Cancer. Ann Surg Oncol 30, 4748–4758 (2023). https://doi.org/10.1245/s10434-023-13593-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-13593-2